Email to a Colleague
Medscape Conference Coverage, based on selected sessions at the:
Fifth International Conference on Bipolar Disorder
June 12 - 14, 2003, Pittsburgh, Pennsylvania

This activity is not sanctioned by, nor a part of, the International Society for Bipolar Disorders.


Topic Overviews
Selected Sessions from the 5th International Conference on Bipolar Disorder CME
Physicians - up to 3 hour(s) of AMA PRA category 1 credit;
Pharmacists - up to 3 contact hour(s) (0.3 CEUs);
Registered Nurses - up to 3.6 Nursing Continuing Education contact hour(s);
Psychologists - up to 3.0 CE credits for Psychologists;

Advances in the Treatment of Bipolar Depression
Irving Kuo, MD
Use of Anticonvulsants and Bipolar Disorder -- Expert Review
Irving Kuo, MD
Children and Adolescents With Bipolar Disorder -- Expert Review
Rachel A. Pollock, PhD
Irving Kuo, MD

 
Conference News
Olanzapine More Effective for Preventing Mania Relapse 6/18/03
[Medscape Medical News]
Almost 30% of the bipolar disorder patients in the lithium group experienced relapse compared with about 14% of those in the olanzapine group.
Quetiapine Effective as Adjunctive Therapy for Acute Mania 6/17/03
[Medscape Medical News]
More patients achieve a response when quetiapine is added to either lithium or divalproex.
Olanzapine-Fluoxetine Combination Shows Rapid Onset in Bipolar Depression 6/17/03
[Medscape Medical News]
At one week, both the combination and olanzapine monotherapy were significantly more effective than placebo as determined by MADRS score.
Rapid Cycling Bipolar Patients Have More Severe Disease 6/16/03
[Medscape Medical News]
These patients also were more likely to be female, have a younger age of onset, and a higher occurrence of depression at study entry.
Adverse Effects From Antidepressants for Bipolar Treatment Are Common in Children 6/16/03
[Medscape Medical News]
This review found that 75% of children experienced adverse effects within the first four months of treatment, a pattern similar to that observed in adult bipolar patients with continuous cycling.

 
Legal Disclaimer
The materials presented here were prepared by independent authors under the editorial supervision of Medscape, and do not represent a publication of the International Society for Bipolar Disorders. These materials and the related activity are not sanctioned by the International Society for Bipolar Disorders or the commercial supporter of the conference, and do not constitute an official part of that conference.
The material presented here does not reflect the views of Medical Education Collaborative, Medscape or the companies providing unrestricted educational grants. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers or continuing education participants should verify all information and data before treating patients or employing any therapies described in this educational activity.
Copyright © 2003 Medscape.

 


Astra Zeneca

All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.